Skip to main content
Clinical Trials/NCT03202420
NCT03202420
Completed
N/A

Pilot Study to Test the Feasibility, Acceptability, and Weight Change of Take Off Pounds Sensibly (TOPS) in a Safety Net Clinic

Duke University1 site in 1 country26 target enrollmentDecember 22, 2017
ConditionsObesity

Overview

Phase
N/A
Intervention
Not specified
Conditions
Obesity
Sponsor
Duke University
Enrollment
26
Locations
1
Primary Endpoint
Change in Weight
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The purpose of this pilot proposal are the following: 1) to determine the feasibility and acceptability of integrating the TOPS weight loss program into underserved populations through an urban safety net clinic and 2) to gather preliminary data of weight change to inform the design of a future randomized, controlled trial to determine the efficacy of the TOPS program in safety net clinics.

To achieve these goals, the investigators will pursue the following Specific Aims:

Specific Aim 1. Assess the feasibility and acceptability of integrating the TOPS program into an urban safety net clinic, with process measures (i.e., recruitment/refusal rates and retention/dropout rates) and focus groups.

Hypothesis 1. Integrating the TOPS program into an urban safety net clinic is feasible and acceptable to participants.

Specific Aim 2. Assess the percent of participants in the TOPS intervention arm with clinically significant weight change (i.e., weight loss of ≥5% of initial body weight) at 12, 26, and 52 weeks.

Hypothesis 2. 10%, 25%, and 33% of participants in the TOPS intervention arm will lose ≥5% of initial body weight at 12, 26, and 52 weeks, respectively.

Registry
clinicaltrials.gov
Start Date
December 22, 2017
End Date
December 5, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Participants must be patients of the DOC.
  • BMI: Asian patients with a BMI of ≥23 kg/m2 and patients of other racial and ethnic backgrounds will be included if have a BMI of ≥25 kg/m
  • Asian patients are allowed to participate at a BMI in the normal range because they are more likely to develop diabetes (or insulin resistance or glucose intolerance at a BMI of 23 kg/m2).

Exclusion Criteria

  • Mental illness that would cause disruptions to group meetings
  • Cognitive impairment that would preclude participants from understanding the program
  • Type 2 diabetics on insulin or sulfonylureas without provider approval
  • untreated hyper- or hypothyroidism
  • current cancer diagnosis
  • history of cancer (other than skin cancer)
  • gastrointestinal disorders affecting food intake
  • use of medications thought to effect metabolism, body weight, energy expenditure, or appetite
  • women currently pregnant or lactating, planning to become pregnant, or less than 6 months post-partum
  • weight loss of \> 5% in past 6 months

Outcomes

Primary Outcomes

Change in Weight

Time Frame: Baseline, 12, 24, and 52 weeks

Weekly weight data will be collected by the DOC Designee at baseline, 12, 24, and 52 weeks.

Secondary Outcomes

  • Retention as measured by attendance sheets(12, 24 and 52 weeks)
  • Program Attendance(52 Weeks)

Study Sites (1)

Loading locations...

Similar Trials